CLINICAL TRIALS PROFILE FOR CANTHARIDIN
✉ Email this page to a colleague
All Clinical Trials for Cantharidin
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00131040 ↗ | Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass | Completed | British Heart Foundation | N/A | 2003-01-01 | The purpose of this study was to see if the heart-lung machine involved in cardiac surgery increases the movement of activated white blood cells from the bloodstream into the patient's tissues and also to see if aprotinin usage during surgery reduces this effect. |
| NCT00131040 ↗ | Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass | Completed | Imperial College London | N/A | 2003-01-01 | The purpose of this study was to see if the heart-lung machine involved in cardiac surgery increases the movement of activated white blood cells from the bloodstream into the patient's tissues and also to see if aprotinin usage during surgery reduces this effect. |
| NCT00667225 ↗ | Efficacy of Cantharidin in Molluscum Contagiosum | Completed | Doris Duke Charitable Foundation | N/A | 2008-01-01 | The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children. |
| NCT00667225 ↗ | Efficacy of Cantharidin in Molluscum Contagiosum | Completed | National Center for Research Resources (NCRR) | N/A | 2008-01-01 | The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children. |
| NCT00667225 ↗ | Efficacy of Cantharidin in Molluscum Contagiosum | Completed | University of North Carolina, Chapel Hill | N/A | 2008-01-01 | The University of North Carolina Department of Dermatology is conducting a clinical trial to evaluate a drug called cantharidin in the treatment of molluscum contagiosum. Molluscum is a common dermatologic disorder caused by a poxvirus. Molluscum typically presents with many flesh-colored bumps on the skin. It goes away on its own, though can last several months to several years. Cantharidin is a topical medicine which is applied at the clinic visit. It is well tolerated by the majority of children. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Cantharidin
Condition Name
Clinical Trial Locations for Cantharidin
Trials by Country
Clinical Trial Progress for Cantharidin
Clinical Trial Phase
Clinical Trial Sponsors for Cantharidin
Sponsor Name
